CIK 0001232524
- Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- EIN
- 981032470
- Phone
- +353 16347800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-03 | Carr Patricia VP, Finance & PAO | Sale | −247 | $119.75 | $30K | 8,153 |
| 2020-02-27 | Swisher Daniel N JR President and COO | Grant or award | +16,000 | 45,126 | ||
| 2020-02-27 | Swisher Daniel N JR President and COO | Grant or award · Incentive Stock Option (right to buy) | +886 | 886 | ||
| 2020-02-27 | Swisher Daniel N JR President and COO | Grant or award · Non-Qualified Stock Option (right to buy) | +39,114 | 39,114 | ||
| 2020-02-27 | Patil Neena M SVP, General Counsel | Grant or award | +8,400 | 20,400 | ||
| 2020-02-27 | Patil Neena M SVP, General Counsel | Grant or award · Incentive Stock Option (right to buy) | +875 | 875 | ||
| 2020-02-27 | Patil Neena M SVP, General Counsel | Grant or award · Non-Qualified Stock Option (right to buy) | +20,125 | 20,125 | ||
| 2020-02-27 | Larkin Finbar SVP, Technical Operations | Grant or award | +5,000 | 15,069 | ||
| 2020-02-27 | Larkin Finbar SVP, Technical Operations | Grant or award · Non-Qualified Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2020-02-27 | Iannone Robert EVP, Research & Development | Grant or award | +10,800 | 23,000 | ||
| 2020-02-27 | Iannone Robert EVP, Research & Development | Grant or award · Incentive Stock Option (right to buy) | +884 | 884 | ||
| 2020-02-27 | Iannone Robert EVP, Research & Development | Grant or award · Non-Qualified Stock Option (right to buy) | +26,116 | 26,116 | ||
| 2020-02-27 | COZADD BRUCE C Chairman & CEO | Grant or award | +52,000 | 355,104 | ||
| 2020-02-27 | COZADD BRUCE C Chairman & CEO | Grant or award · Incentive Stock Option (right to buy) | +885 | 885 | ||
| 2020-02-27 | COZADD BRUCE C Chairman & CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +129,115 | 129,115 | ||
| 2020-02-27 | Carr Patricia VP, Finance & PAO | Grant or award | +2,600 | 8,400 | ||
| 2020-02-27 | Carr Patricia VP, Finance & PAO | Grant or award · Non-Qualified Stock Option (right to buy) | +6,500 | 6,500 | ||
| 2020-02-25 | COZADD BRUCE C Chairman & CEO | Shares withheld for taxes | −2,679 | $127.25 | $341K | 303,104 |
| 2020-02-24 | COZADD BRUCE C Chairman & CEO | Option exercise | +6,895 | $11.48 | $79K | 305,783 |
| 2020-02-24 | COZADD BRUCE C Chairman & CEO | Option exercise · Incentive Stock Option (right to buy) | −6,895 | 0 |
Page 39 of 39 · 780 trades